Rotella Capital Management, Inc. - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 223 filers reported holding PDL BIOPHARMA INC in Q4 2014. The put-call ratio across all filers is 2.49 and the average weighting 0.0%.

Quarter-by-quarter ownership
Rotella Capital Management, Inc. ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q4 2015$395,000
-72.3%
111,491
-60.7%
0.35%
-23.4%
Q3 2015$1,427,000
+659.0%
283,754
+868.4%
0.46%
+197.4%
Q2 2015$188,000
-25.7%
29,300
-18.6%
0.16%
-26.9%
Q1 2015$253,000
+3.7%
36,000
+13.6%
0.21%0.0%
Q4 2014$244,000
+95.2%
31,700
+89.8%
0.21%
+61.8%
Q3 2014$125,000
-41.9%
16,700
-24.8%
0.13%
-28.0%
Q2 2014$215,00022,2000.18%
Other shareholders
PDL BIOPHARMA INC shareholders Q4 2014
NameSharesValueWeighting ↓
Argent Trust Co 41,405$102,2700.01%
Diversified Trust Co 11,029$26,4690.00%
HANCOCK WHITNEY CORP 128,396$00.00%
RHUMBLINE ADVISERS 612$1,5110.00%
Ancora Advisors LLC 4,948$00.00%
Westside Investment Management, Inc. 500$00.00%
View complete list of PDL BIOPHARMA INC shareholders